NEWS ACCESS BIO
ANNOUNCEMENT OF THE RECORD DATE FOR DETERMINING SHAREHOLDERS

ANNOUNCEMENT OF THE RECORD DATE FOR DETERMINING SHAREHOLDERS

In accordance with Article 16 (1) of the “Korean Depository Receipt Agreement” signed between Access Bio and Korea Securities Depository on March 11, 2013, the Record Date for determining shareholders in 2020 is December 31, 2020.

GETTING TESTS WHERE THEY’RE NEEDED MOST

GETTING TESTS WHERE THEY’RE NEEDED MOST

Access Bio was founded on the basic principle of cherishing life and health for all people. The company has emerged as a leader in the diagnosis of infectious diseases. Although it provides a comprehensive portfolio, Access Bio is known for its work against malaria, HIV, HPV, and now, COVID-19.

THE GOAL: ENDING MALARIA IN OUR LIFETIME

THE GOAL: ENDING MALARIA IN OUR LIFETIME

Malaria and its effects are primarily concentrated in poor, developing nations. in 2018, there were an estimated 228 million cases around the world and more than 400,000 deaths. Of those, more than 90% of cases and mortalities occurred in the sub-Saharan region of Africa, and children under the age of 5 account for two-thirds of all malaria deaths worldwide.